ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection

K. Miki, K. Iwadoh, I. Nakajima, S. Fuchinoue.

Tokyo Women Medical University, Kidney Center, Tokyo, Kawadacho, Japan.

Meeting: 2015 American Transplant Congress

Abstract number: C211

Keywords: Pancreas transplantation

Session Information

Date: Monday, May 4, 2015

Session Name: Poster Session C: More Controversies in Pancreas Transplantation

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Related Abstracts
  • Preliminary Results of a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab in a Pediatric Patient Population Undergoing Kidney Transplantation
  • Single Center Experience With the Use of an Abbreviated Anti-Thymocyte Globulin and Basiliximab Combination Protocol in Renal Transplantation

【Background】Induction therapy in simultaneous pancreas-kidney transplant (SPK) recipients has been a common practice because a consequence of acute rejection (AR) in SPK could result in a serious situation. Although a single IL-2 receptor antibody induction had been popular here in Japan for years, AR incidence rate was still high. We recently adopted a dual induction with anti-thymocyte globulin (ATG) and basiliximab (BXM) in SPK and now report its clinical results.

【Method】We conducted 19 SPK between 2010 and 2014. A single induction therapy (SIT) with BXM was applied in 12 cases until 2012. After 2013, a dual induction therapy (DIT) with ATG and BXM was used. We compared their clinical consequences.

【Results】Average donor/recipient ages of SIT group vs. DIT group were 40.4±15.8 vs. 37.3±6.5/ 45.2±4.8 vs. 45.4±9.9, respectively. The regimen in SIT consisted of tacrolimus, MMF and steroid with BXM. That in DIT was composed of tacrolimus ER, MMF and steroid with ATG and BXM and everolimus was added later. 1-year graft survival rates of DIT vs. SIT were 7/7 (100%) vs. 11/12(91.7%), respectively. 12-month AR free ratios of DIT vs. SIT were 100% vs. 83.3% (p=0.269), respectively. No AR was found in DIT group for 17 months at longest after surgery. Significant white blood count or platelet count decline was not detected in DIT group compared to SIT. There was also no significant difference in PCP, CMV or urinary tract infection (UTI) incidence between two groups.

【Conclusion】SPK recipients who received DIT with ATG and BXM showed no AR and no graft loss for 17 months at most after transplant. Although there was no significant statistical difference of AR incidence between DIT and SIT probably due to lack of statistical power, DIT has safely reduced incidence of AR in SPK with no apparent adverse event increaed.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Miki K, Iwadoh K, Nakajima I, Fuchinoue S. Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/dual-induction-therapy-with-anti-thymocyte-globulin-and-basiliximab-in-simultaneous-pancreas-kidney-transplantation-reduced-incidence-of-acute-rejection/. Accessed January 25, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.